Long-term effects of nigro-striatal denervation of striatal [3H]haloperidol binding. 1981

C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet

UI MeSH Term Description Entries
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine

Related Publications

C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
January 1984, Psychopharmacology bulletin,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
November 1976, Neuroscience letters,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
February 1973, Diseases of the nervous system,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
March 1984, Naunyn-Schmiedeberg's archives of pharmacology,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
December 1983, Brain research bulletin,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
January 1980, Advances in biochemical psychopharmacology,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
January 1989, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
August 1978, Life sciences,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
August 1985, European journal of pharmacology,
C Feuerstein, and P Demenge, and G Barrette, and C Silice, and B Guerin, and P Mouchet
January 1981, Neurobiology of aging,
Copied contents to your clipboard!